Filing metadata

Accession number
0001209191-21-043549
Form type
Form 4
Filer
Ultragenyx Pharmaceutical Inc.
CIK
CIK 1515673
Filed
Jun 28, 2021
Reporting period
Jun 24, 2021
Description
Insider transaction

Explore SEC Filings Hub